» Articles » PMID: 24673908

Assessment of the Toxic Potential of Graphene Family Nanomaterials

Overview
Date 2014 Mar 29
PMID 24673908
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Graphene, a single-atom-thick carbon nanosheet, has attracted great interest as a promising nanomaterial for a variety of bioapplications because of its extraordinary properties. However, the potential for widespread human exposure raises safety concerns about graphene and its derivatives, referred to as graphene-family nanomaterials. This review summarizes recent findings on the toxicological effects and the potential toxicity mechanisms of graphene-family nanomaterials in bacteria, mammalian cells, and animal models. Graphene, graphene oxide, and reduced graphene oxide elicit toxic effects both in vitro and in vivo, whereas surface modifications can significantly reduce their toxic interactions with living systems. Standardization of terminology and the fabrication methods of graphene-family nanomaterials are warranted for further investigations designed to decrease their adverse effects and explore their biomedical applications.

Citing Articles

Nanocomposites Based on Iron Oxide and Carbonaceous Nanoparticles: From Synthesis to Their Biomedical Applications.

Vaduva M, Nila A, Udrescu A, Cramariuc O, Baibarac M Materials (Basel). 2025; 17(24.

PMID: 39769728 PMC: 11676432. DOI: 10.3390/ma17246127.


Nanoparticles in Bone Regeneration: A Narrative Review of Current Advances and Future Directions in Tissue Engineering.

Farjaminejad S, Farjaminejad R, Garcia-Godoy F J Funct Biomater. 2024; 15(9).

PMID: 39330217 PMC: 11432802. DOI: 10.3390/jfb15090241.


Short term biodistribution and in vivo toxicity assessment of intravenously injected pristine graphene oxide nanoflakes in SD rats.

De I, Singh R, Kumar S, Singh S, Singh M, Panda J Toxicol Res (Camb). 2024; 13(2):tfae058.

PMID: 38617714 PMC: 11014786. DOI: 10.1093/toxres/tfae058.


Comprehensive Assessment of Graphene Oxide Nanoparticles: Effects on Liver Enzymes and Cardiovascular System in Animal Models and Skeletal Muscle Cells.

Keremidarska-Markova M, Sazdova I, Ilieva B, Mishonova M, Shkodrova M, Hristova-Panusheva K Nanomaterials (Basel). 2024; 14(2).

PMID: 38251152 PMC: 10818754. DOI: 10.3390/nano14020188.


Ameliorating Effects of Graphene Oxide on Cadmium Accumulation and Eco-Physiological Characteristics in a Greening Hyperaccumulator ( Thunb.).

Liu Z, Lu Q, Zhao Y, Wei J, Liu M, Duan X Plants (Basel). 2024; 13(1).

PMID: 38202327 PMC: 10780341. DOI: 10.3390/plants13010019.


References
1.
Robinson J, Tabakman S, Liang Y, Wang H, Sanchez Casalongue H, Vinh D . Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011; 133(17):6825-31. DOI: 10.1021/ja2010175. View

2.
Dikin D, Stankovich S, Zimney E, Piner R, Dommett G, Evmenenko G . Preparation and characterization of graphene oxide paper. Nature. 2007; 448(7152):457-60. DOI: 10.1038/nature06016. View

3.
Liu G, Shen H, Mao J, Zhang L, Jiang Z, Sun T . Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. ACS Appl Mater Interfaces. 2013; 5(15):6909-14. DOI: 10.1021/am402128s. View

4.
Zhi X, Fang H, Bao C, Shen G, Zhang J, Wang K . The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials. 2013; 34(21):5254-61. DOI: 10.1016/j.biomaterials.2013.03.024. View

5.
Hu H, Yu J, Li Y, Zhao J, Dong H . Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J Biomed Mater Res A. 2011; 100(1):141-8. DOI: 10.1002/jbm.a.33252. View